Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection, Mixed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05268185
What this trial is testing

The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19)

Who this might be right for
COVID-19Vaccine ReactionCOVID-19 Pandemic
University of California, San Francisco 301
Large-scale testing (Phase 3)WithdrawnNCT00243568
What this trial is testing

Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC
Not applicableLooking for participantsNCT06397794
What this trial is testing

Navigating Pregnancy and Parenthood With Lyme Disease

Who this might be right for
Lyme DiseasePost Treatment Lyme DiseaseChronic Lyme Disease+4 more
Children's National Research Institute 30
Testing effectiveness (Phase 2)Study completedNCT00003039
What this trial is testing

Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT03822156
What this trial is testing

Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort

Who this might be right for
TuberculosisTuberculosis, PulmonaryCavity+5 more
University of Ulsan 500
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Not applicableStudy completedNCT00416312
What this trial is testing

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Not applicableUnknownNCT04702412
What this trial is testing

Electronic Capture of Adherence Barriers for HIV Care

Who this might be right for
HIV Infections
McGill University Health Centre/Research Institute of the McGill University Health Centre 30
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00691015
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Barbara Ann Karmanos Cancer Institute 48
Not applicableActive Not RecruitingNCT07519538
What this trial is testing

Southern Sichuan HIV Cohort Study Protocol

Who this might be right for
HIV - Human Immunodeficiency Virus
Southwest Medical University 10
Testing effectiveness (Phase 2)Study completedNCT00059358
What this trial is testing

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 16
Not applicableStudy completedNCT05630391
What this trial is testing

High-Fidelity Simulation Training: A Mixed Method Study

Who this might be right for
Simulation of Physical IllnessSatisfaction
Sakarya University 52
Not applicableUnknownNCT04594460
What this trial is testing

Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19Hydrogen-oxygen GasAMS-H-03
Guangzhou Institute of Respiratory Disease 198
Post-approval studies (Phase 4)UnknownNCT04032860
What this trial is testing

RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection

Who this might be right for
HCCHBV Coinfection
West China Hospital 104
Testing effectiveness (Phase 2)Ended earlyNCT00003113
What this trial is testing

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center 6
Not applicableStudy completedNCT04979897
What this trial is testing

Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic

Who this might be right for
Covid19Critical CarePostintensive Care Syndrome
Universidad del Desarrollo 252
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Next Page